{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:06:39Z","timestamp":1782781599914,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172626"],"award-info":[{"award-number":["82172626"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Emerging Medical Professionals","award":["TJSQNYXXR-D2-078"],"award-info":[{"award-number":["TJSQNYXXR-D2-078"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-031A"],"award-info":[{"award-number":["TJYXZDXK-031A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s43032-025-01874-y","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:56:33Z","timestamp":1747652193000},"page":"3468-3480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Factors of Oncologic and Reproductive Outcomes in Conservative Therapy of Endometrial Hyperplasia and Endometrial Cancer: Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5858-1481","authenticated-orcid":false,"given":"Ling","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"10333","key":"1874_CR1","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/s0140-6736(22):00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(22):00323-3.","journal-title":"Lancet"},{"key":"1874_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708","author":"LS Rebecca","year":"2022","unstructured":"Rebecca LS, Kimberly DM, Hannah EF, Ahmedin J. Cancer statistics, 2022. CA Cancer J Clin. 2022. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1874_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","volume":"21","author":"N Abu-Rustum","year":"2023","unstructured":"Abu-Rustum N, Yashar C, Arend R, et al. Uterine neoplasms, Version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(2):181\u2013209. https:\/\/doi.org\/10.6004\/jnccn.2023.0006.","journal-title":"J Natl Compr Canc Netw"},{"key":"1874_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14815","author":"S Zhao","year":"2024","unstructured":"Zhao S, Zhang J, Yan Y, et al. Oncological and reproductive outcomes of endometrial atypical hyperplasia and endometrial cancer patients undergoing conservative therapy with hysteroscopic resection: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2024. https:\/\/doi.org\/10.1111\/aogs.14815.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1874_CR5","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle- Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in\u00a0meta-analysis. 2023.\u00a0Retrieved\u00a0from\u00a0https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"11","key":"1874_CR6","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3969\/j.issn.1001-5930.2023.11.039","volume":"38","author":"H Yue","year":"2023","unstructured":"Yue H, Li J. Analysis of the effect and recurrence of progesterone combined with hysteroscopy in the treatment of early endometrial cancer and atypical hyperplasia. Pract J Cancer. 2023;38(11):1903\u20136. https:\/\/doi.org\/10.3969\/j.issn.1001-5930.2023.11.039.","journal-title":"Pract J Cancer"},{"issue":"3","key":"1874_CR7","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.3802\/jgo.2023.34.e38","volume":"34","author":"K Ushijima","year":"2023","unstructured":"Ushijima K, Tsuda N, Yamagami W, et al. Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the gynecologic oncology committee of the Japan Society of obstetrics and gynecology. J Gynecol Oncol. 2023;34(3):e38. https:\/\/doi.org\/10.3802\/jgo.2023.34.e38.","journal-title":"J Gynecol Oncol"},{"issue":"12","key":"1874_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1136\/ijgc-2022-003882","volume":"32","author":"J Chen","year":"2022","unstructured":"Chen J, Cao D, Yang J, et al. Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia. Int J Gynecol Cancer. 2022;32(12):1561\u20137. https:\/\/doi.org\/10.1136\/ijgc-2022-003882.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"1874_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3760\/cma.j.cn112141-20220727-00487","volume":"57","author":"L Bo","year":"2022","unstructured":"Bo L, Wang YQ, Liu YY. Analyze of obesity indicators and effect of fertility preservation treatment in patients with endometrial atypical hyperplasia and early endometrial cancer. Zhonghua Fu Chan Ke Za Zhi. 2022;57(10):767\u201374. https:\/\/doi.org\/10.3760\/cma.j.cn112141-20220727-00487.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"03","key":"1874_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3969\/j.issn.1673-5412.2022.03.010","volume":"35","author":"J Shi","year":"2022","unstructured":"Shi J, He NN, Zhao Z, et al. Analysis of prognosis and reproductive outcome of endometrial atypical hyperplasia and early endometrial carcinoma treated by hysteroscopy combined with progester-one. J Basic Cli Oncol. 2022;35(03):222\u20136. https:\/\/doi.org\/10.3969\/j.issn.1673-5412.2022.03.010.","journal-title":"J Basic Cli Oncol"},{"issue":"3","key":"1874_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.11877\/j.issn.1672-1535.2022.20.03.22","volume":"20","author":"JM Xu","year":"2022","unstructured":"Xu JM, Hu R, Li LP, et al. Influence factors of recurrence after fertility preservation therapy in patients with early endometrial carcinoma and precancerous lesions. Oncol Prog. 2022;20(3):297\u2013300. https:\/\/doi.org\/10.11877\/j.issn.1672-1535.2022.20.03.22.","journal-title":"Oncol Prog"},{"issue":"19","key":"1874_CR12","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.11877\/j.issn.1672-1535.2021.19.19.23","volume":"19","author":"N Li","year":"2021","unstructured":"Li N, Guo Q. Analysis of influencing factors of pregnancy outcome in patients with endometrial cancer after high-dose progesterone therapy. Oncol Prog. 2021;19(19):2024\u20137. https:\/\/doi.org\/10.11877\/j.issn.1672-1535.2021.19.19.23.","journal-title":"Oncol Prog."},{"issue":"1","key":"1874_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12958-021-00808-y","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Li X, Wang J, et al. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol. 2021;19(1):118. https:\/\/doi.org\/10.1186\/s12958-021-00808-y.","journal-title":"Reprod Biol Endocrinol"},{"key":"1874_CR14","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.2147\/cmar.S316040","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li D, Yan Q, et al. Weight loss improves pregnancy and livebirth outcomes in young women with early-stage endometrial cancer and atypical hyperplasia. Cancer Manag Res. 2021;13:5711\u201322. https:\/\/doi.org\/10.2147\/cmar.S316040.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"1874_CR15","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.3802\/jgo.2021.32.e57","volume":"32","author":"S Zhou","year":"2021","unstructured":"Zhou S, Xu Z, Yang B, et al. Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment. J Gynecol Oncol. 2021;32(4):e57. https:\/\/doi.org\/10.3802\/jgo.2021.32.e57.","journal-title":"J Gynecol Oncol"},{"issue":"5","key":"1874_CR16","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e70","volume":"32","author":"L Wang","year":"2021","unstructured":"Wang L, Luo X, Wang Q, et al. Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome. J Gynecol Oncol. 2021;32(5): e70. https:\/\/doi.org\/10.3802\/jgo.2021.32.e70.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"1874_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.rbmo.2021.06.007","volume":"43","author":"M Vaugon","year":"2021","unstructured":"Vaugon M, Peign\u00e9 M, Phelippeau J, Gonthier C, Koskas M. IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management. Reprod Biomed Online. 2021;43(3):495\u2013502. https:\/\/doi.org\/10.1016\/j.rbmo.2021.06.007.","journal-title":"Reprod Biomed Online"},{"key":"1874_CR18","doi-asserted-by":"publisher","first-page":"808881","DOI":"10.3389\/fonc.2021.808881","volume":"11","author":"Y He","year":"2021","unstructured":"He Y, Wang J, Wang Y, et al. Maintenance therapy can improve the oncologic prognosis and obstetrical outcome of patients with atypical endometrial hyperplasia and endometrial cancer after fertility-preserving treatment: a multicenter retrospective study. Front Oncol. 2021;11:808881.","journal-title":"Front Oncol"},{"issue":"7","key":"1874_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.19790\/j.cnki.JCM.2021.07.08","volume":"19","author":"XY Meng","year":"2021","unstructured":"Meng XY, Wang Y. Analysis of influencing factors of pregnancy in patients with endometrial carcinoma after efficiently progestational hormone therapy. J Community Med. 2021;19(7):428\u201330. https:\/\/doi.org\/10.19790\/j.cnki.JCM.2021.07.08.","journal-title":"J Community Med"},{"issue":"12","key":"1874_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3760\/cma.j.cn112141-20200613-00501","volume":"55","author":"ZR Xiao","year":"2020","unstructured":"Xiao ZR, Lu Q, Zhou R, et al. Analysis of pregnancy outcome after fertility-preserving treatment among women with atypical endometrial hyperplasia or endometrial carcinoma. Zhonghua Fu Chan Ke Za Zhi. 2020;55(12):857\u201364. https:\/\/doi.org\/10.3760\/cma.j.cn112141-20200613-00501.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"3","key":"1874_CR21","first-page":"1525","volume":"25","author":"Z Xu","year":"2020","unstructured":"Xu Z, Tian Y, Fu J, Xu J, Bao D, Wang G. Efficacy and prognosis of fertility-preserved hysteroscopic surgery combined with progesterone in the treatment of complex endometrial hyperplasia and early endometrial carcinoma. J buon. 2020;25(3):1525\u201333.","journal-title":"J buon"},{"issue":"4","key":"1874_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5935\/1518-0557.20200037","volume":"24","author":"S Shikeli","year":"2020","unstructured":"Shikeli S, Gowri V, Rawahi TA. Fertility-sparing treatment in young women with atypical endometrial hyperplasia and low-grade endometrial cancer: a tertiary center experience. JBRA Assist Reprod. 2020;24(4):466\u20139. https:\/\/doi.org\/10.5935\/1518-0557.20200037.","journal-title":"JBRA Assist Reprod"},{"issue":"4","key":"1874_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/1940-6207.Capr-19-0399","volume":"13","author":"J Yin","year":"2020","unstructured":"Yin J, Ma S, Shan Y, et al. Risk factors for recurrence in patients with atypical endometrial hyperplasia and endometrioid adenocarcinoma after fertility-sparing treatments. Cancer Prev Res (Phila). 2020;13(4):403\u201310. https:\/\/doi.org\/10.1158\/1940-6207.Capr-19-0399.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"1874_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","volume":"153","author":"B Yang","year":"2019","unstructured":"Yang B, Xu Y, Zhu Q, et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol. 2019;153(1):55\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2019.01.014.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1874_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00404-019-05059-2","volume":"299","author":"MA Ciccone","year":"2019","unstructured":"Ciccone MA, Whitman SA, Conturie CL. Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia. Arch Gynecol Obstet. 2019;299(3):801\u20138. https:\/\/doi.org\/10.1007\/s00404-019-05059-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1874_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","volume":"29","author":"SH Chae","year":"2019","unstructured":"Chae SH, Shim SH, Lee SJ. Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer. Int J Gynecol Cancer. 2019;29(1):77\u201385. https:\/\/doi.org\/10.1136\/ijgc-2018-000036.","journal-title":"Int J Gynecol Cancer"},{"key":"1874_CR27","doi-asserted-by":"publisher","unstructured":"Kang LP, Liu L, He W. Prognosis of patients with endometrial complex atypical hyperplasia and early endometrial cancer treated by highly effective progestogen therapy. J Hunan Normal University(Med Sci). 16(5), 122\u2013125. https:\/\/doi.org\/10.3969\/j.issn.1673-016X.2019.05.038.","DOI":"10.3969\/j.issn.1673-016X.2019.05.038"},{"issue":"3","key":"1874_CR28","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.3802\/jgo.2018.29.e35","volume":"29","author":"B Yang","year":"2018","unstructured":"Yang B, Xie L, Zhang H, et al. Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients. J Gynecol Oncol. 2018;29(3):e35. https:\/\/doi.org\/10.3802\/jgo.2018.29.e35.","journal-title":"J Gynecol Oncol"},{"issue":"01","key":"1874_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3969\/j.issn.1674-4020.2018.01.07","volume":"10","author":"WH Yuan","year":"2018","unstructured":"Yuan WH, Shi HR. Prognosis analysis of fertility maintenance in women with complex endometrial hyperplasia or endometrial cancer. Chin J Family Planning & Gynecot. 2018;10(01):23\u20137. https:\/\/doi.org\/10.3969\/j.issn.1674-4020.2018.01.07.","journal-title":"Chin J Family Planning & Gynecot"},{"issue":"1","key":"1874_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jog.13473","volume":"44","author":"S Tamauchi","year":"2018","unstructured":"Tamauchi S, Kajiyama H, Utsumi F, et al. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res. 2018;44(1):151\u20136. https:\/\/doi.org\/10.1111\/jog.13473.","journal-title":"J Obstet Gynaecol Res"},{"key":"1874_CR31","doi-asserted-by":"publisher","unstructured":"Li MM,Wu YM (2018).Effect of high performance progestogen on endometrial carcinoma\/endometrial atypical hyperplasia and analysis of factors affecting pregnancy outcome. Oncol Progress. 16(8), 987\u2013989,1055. https:\/\/doi.org\/10.11877\/j.issn.1672-1535.2018.16.08.18","DOI":"10.11877\/j.issn.1672-1535.2018.16.08.18"},{"issue":"1","key":"1874_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","volume":"132","author":"M Chen","year":"2016","unstructured":"Chen M, Jin Y, Li Y, et al. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. Int J Gynaecol Obstet. 2016;132(1):34\u20138. https:\/\/doi.org\/10.1016\/j.ijgo.2015.06.046.","journal-title":"Int J Gynaecol Obstet"},{"key":"1874_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12958-015-0136-7","volume":"14","author":"O Inoue","year":"2016","unstructured":"Inoue O, Hamatani T, Susumu N, et al. Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol. 2016;14:2. https:\/\/doi.org\/10.1186\/s12958-015-0136-7.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"1874_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ygyno.2015.09.078","volume":"139","author":"R Zhou","year":"2015","unstructured":"Zhou R, Yang Y, Lu Q, et al. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients. Gynecol Oncol. 2015;139(3):424\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2015.09.078.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1874_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ygyno.2015.10.015","volume":"139","author":"YF Yang","year":"2015","unstructured":"Yang YF, Liao YY, Liu XL. Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment. Gynecol Oncol. 2015;139(3):419\u201323. https:\/\/doi.org\/10.1016\/j.ygyno.2015.10.015.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1874_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/igc.0000000000000098","volume":"24","author":"CJ Wang","year":"2014","unstructured":"Wang CJ, Chao A, Yang LY, et al. Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study. Int J Gynecol Cancer. 2014;24(4):718\u201328. https:\/\/doi.org\/10.1097\/igc.0000000000000098.","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"1874_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3760\/cma.j.issn.1673-4904.2014.18.008","volume":"37","author":"GM Feng","year":"2014","unstructured":"Feng GM, Peng YH. Pregnancy outcome of giving large doses of oral progesterone in early endometrial cancer and endometrial severe dysplasia. Chin J Postgraduates Med. 2014;37(18):24\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.1673-4904.2014.18.008.","journal-title":"Chin J Postgraduates Med"},{"issue":"1","key":"1874_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","volume":"133","author":"C Gonthier","year":"2014","unstructured":"Gonthier C, Walker F, Luton D, et al. Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer. Gynecol Oncol. 2014;133(1):33\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2013.11.007.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1874_CR39","first-page":"519","volume":"48","author":"DY Cao","year":"2013","unstructured":"Cao DY, Yu M, Yang JX, et al. Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin. Zhonghua Fu Chan Ke Za Zhi. 2013;48(7):519\u201322.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"1874_CR40","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","volume":"49","author":"JY Park","year":"2013","unstructured":"Park JY, Kim DY, Kim JH, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer. 2013;49(4):868\u201374. https:\/\/doi.org\/10.1016\/j.ejca.2012.09.017.","journal-title":"Eur J Cancer"},{"issue":"48","key":"1874_CR41","doi-asserted-by":"publisher","first-page":"e27961","DOI":"10.1097\/md.0000000000027961","volume":"100","author":"XL Zhao","year":"2021","unstructured":"Zhao XL, Du ZQ, Zhang X, et al. Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100(48):e27961. https:\/\/doi.org\/10.1097\/md.0000000000027961.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1874_CR42","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","volume":"125","author":"CC Gunderson","year":"2012","unstructured":"Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125(2):477\u201382. https:\/\/doi.org\/10.1016\/j.ygyno.2012.01.003.","journal-title":"Gynecol Oncol"},{"issue":"34","key":"1874_CR43","doi-asserted-by":"publisher","first-page":"57642","DOI":"10.18632\/oncotarget.17588","volume":"8","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Qi G, Kanis MJ, et al. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget. 2017;8(34):57642\u201353. https:\/\/doi.org\/10.18632\/oncotarget.17588.","journal-title":"Oncotarget"},{"issue":"2","key":"1874_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/igc.0000000000001164","volume":"28","author":"Z Fan","year":"2018","unstructured":"Fan Z, Li H, Hu R, et al. Fertility-preserving treatment in young women with grade 1 presumed stage ia endometrial adenocarcinoma: a meta-analysis. Int J Gynecol Cancer. 2018;28(2):385\u201393. https:\/\/doi.org\/10.1097\/igc.0000000000001164.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"1874_CR45","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ygyno.2021.04.017","volume":"161","author":"SM Lucchini","year":"2021","unstructured":"Lucchini SM, Esteban A, Nigra MA, Palacios AT. Updates on conservative management of endometrial cancer in patients younger than 45 years. Gynecol Oncol. 2021;161(3):802\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2021.04.017.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1874_CR46","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ijc.31961","volume":"145","author":"O Raglan","year":"2019","unstructured":"Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer. 2019;145(7):1719\u201330. https:\/\/doi.org\/10.1002\/ijc.31961.","journal-title":"Int J Cancer"},{"issue":"3","key":"1874_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ijgo.12882","volume":"146","author":"S Guillon","year":"2019","unstructured":"Guillon S, Popescu N, Phelippeau J, Koskas M. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma. Int J Gynaecol Obstet. 2019;146(3):277\u201388. https:\/\/doi.org\/10.1002\/ijgo.12882.","journal-title":"Int J Gynaecol Obstet"},{"key":"1874_CR48","doi-asserted-by":"publisher","unstructured":"The American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and The Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril. 2014;101(3):633\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.12.032.","DOI":"10.1016\/j.fertnstert.2013.12.032"},{"key":"1874_CR49","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Obesity and reproduction. a committee opinion. Fertil Steril. 2021;116(5):1266\u201385. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.08.018.","DOI":"10.1016\/j.fertnstert.2021.08.018"},{"issue":"5","key":"1874_CR50","doi-asserted-by":"publisher","first-page":"474.e471","DOI":"10.1016\/j.ajog.2019.05.029","volume":"221","author":"RF Harrison","year":"2019","unstructured":"Harrison RF, He W, Fu S, et al. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019;221(5):474.e471-474.e411. https:\/\/doi.org\/10.1016\/j.ajog.2019.05.029.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01874-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-01874-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-01874-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:55:11Z","timestamp":1765374911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-01874-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-01874-y","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study, being a systematic review and meta-analysis, did not require ethical approval. However, the study protocol can be observed at the PROSPERO International prospective register of systematic reviews (\n                      \n                      , registration ID- CRD42023469986) and was registered prior to initiating the meta-analysis. Other informed consent was not applicable in this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}